News
12.05.11 - XBiotech Presents Oncology Trial Results
09.24.11 - XBiotech Hosts Clinical Investigators
09.12.11 - Early Results from XBiotech’s Clinical Study in Cachexia…
08.30.11 - XBiotech Launches Partnership Talks in Asia
08.18.11 - All Five U.S. Sites for Restenosis Clinical Trial…
07.18.11 - XBiotech Enrolls 1st Patient in Restenosis Study
07.01.11 - XBiotech Receives FDA Approval
07.01.11 - New Media Formulation in the Works
06.01.11 - XBiotech closes deal with South Texas…
05.03.11 - XBiotech Receives Swissmedic Approval
04.13.11 - XBiotech Receives FDA Approval
04.06.11 - XBiotech Closes Funding Round
04.01.11 - XBiotech Receives FDA Approval
04.01.11 - XBiotech purchases the First ClonePix™ 2
01.21.11 - XBiotech files IND for Type 2 Diabetes
12.22.10 - XBiotech files IND for Peripheral Vascular Disease
11.22.10 - XBiotech files IND for Myelogenous Leukemia
11.15.10 - XBiotech launches new funding round
06.18.10 - The next investigational drug application is set to launch
06.14.10 - A Phase I/II clinical trial is showing potential benefits
06.01.10 - XBiotech Scientists develop new methodology…
03.05.10 - XBiotech scientists have developed a simple and inexpensive…